ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Trial ID or NCT#

NCT00981578

Status

not recruiting iconNOT RECRUITING

Purpose

A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.

Official Title

A Feasibility Study to Evaluate the Safety and Initial Effectiveness of ExAblate MR Guided Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

David Hovsepian
David Hovsepian
Interventional radiologist, Radiologist
Clinical Professor, Radiology - Pediatric Radiology
Pejman Ghanouni
Pejman Ghanouni
Radiologist
Professor of Radiology (Body MRI) and, by courtesy, of Neurosurgery, of Obstetrics and Gynecology and of Urology

Contact us to find out if this trial is right for you.

Contact

CCTO
650-498-7061

View on ClinicalTrials.gov